CharlesBenjaminBernickMDMPH

Neurology • Las Vegas, NV

Neurodegenerative, Neurodevelopmental Disabilities

Neurologist, Cleveland Clinic

Join to view full profile

Dr. Bernick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bernick's full profile

Already have an account?

Office
888 W. Bonneville Ave
Las Vegas, NV 89106
Phone+1 702-497-1383

Education & Training

University of Arizona College of Medicine-TucsonResidency, Neurology, 1984 - 1986
University of Miami/Jackson Health SystemResidency, Neurology, 1981 - 1984
University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1980 - 1981
University of Texas Southwestern Medical SchoolClass of 1980

Certifications & Licensure

WA State Medical License 2019 - 2026
NV State Medical License 1993 - 2025
FL State Medical License 1982 - 1985
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Completed
Phase 3
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Olfactory Function Is Reduced in a Subset of Former Elite American Football Players with Traumatic Encephalopathy Syndrome.
Ben J Braunecker, Jenna R Groh, Charles H Adler, Michael L Alosco, David W Dodick
Chemical Senses. 2024-12-09
Conversion to Alzheimer's disease dementia from normal cognition directly or with the intermediate mild cognitive impairment stage.
Xinlin Lu, Yahui Zhang, Yichen Tang, Charles Bernick, Guogen Shan
Alzheimer's & Dementia. 2024-11-19
Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players.
Annalise E Miner, Jenna R Groh, Yorghos Tripodis, Charles H Adler, Laura J Balcer
Alzheimer's & Dementia. 2024-11-01

Lectures

Arrowhead's 3rd Annual Traumatic Brain Injury Conference
Arrowhead Publishers and Conferences, Arlington, Virginia - 3/6/2013

Press Mentions

Scientists Studying Weight Loss Drugs Ozempic and Wegovy to Treat DEMENTIAMay 8th, 2023
New, Promising Drug to Change Game Against Alzheimer's DiseaseDecember 1st, 2022
New Study Correlates Increased Sparring with Brain Changes in Mixed Martial ArtsMay 21st, 2022
Join now to see all